 |
Atul
K. Bhan, M.B.B.S., M.D.
Professor
of Pathology, Harvard Medical School
Director of the Immunopathology Unit
Department of Pathology
Massachusetts General Hospital
Department of Pathology – WRN 501
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-726-2588
Fax: 617-726-2365
Email: abhan@partners.org
Affiliations:
Center for the Study of Inflammatory Bowel Disease,
Massachusetts General Hospital
|
Sign out: Liver
transplantation, prognostic markers for breast cancer
and autopsy.
Research Interests:
In the two major forms of IBD, Crohn’s disease
and ulcerative colitis, the underlying etiological
factors and the pathogenesis remain poorly defined.
It is generally believed that exaggerated immune responses
to luminal antigens due to loss of tolerance to normal
enteric flora are involved in the initiation and perpetuation
of the disease process. Whether IBD pathogenesis has
an important autoimmune component has not been resolved
yet.
The recent availability of a wide variety of experimental
models of intestinal inflammation has helped provide
important clues about the pathogenesis of IBD. The
commonly used models include chemically induced mucosal
injury and colitis induced by the transfer of selected
populations of T cells into immunodeficient mice.
The spontaneous development of colitis in genetically
engineered animal models, including T cell receptor
(TCR) alpha KO mice, and mice deficient in IL-2, IL-10,
and the Wiskott- Aldrich syndrome protein (WASP) have
provided excellent experimental models to study the
pathogenesis of IBD. One important lesson learned
from IBD models is that many different immunologic
and mucosal defects can lead to similar pathologic
findings.
For the last several years, our laboratory has focused
on defining the pathogenesis of chronic intestinal
inflammation using TCR alpha KO mice as a model of
human IBD. TCR alpha KO mice develop spontaneously
chronic colitis with many features of ulcerative colitis.
These include restriction of inflammation to the colon
and the mucosa, presence of autoantibodies, the protective
role of appendectomy and pathogenic role of Th-2 pathway
in the development of colitis. We have recently identified
a regulatory B cell subset, which appears under chronic
intestinal inflammatory conditions and suppresses
the progression of intestinal inflammation by secreting
IL-10. TCR alpha KO mice deficient in both IL-4 and
B cells, but not in IL-4 alone, develop granulomatous
colitis with features of Crohn’s disease. This
suggests that differences in the two major forms of
IBD may reflect different immunological responses
to similar initiating events. The laboratory is closely
associated with the Center for the Study of Inflammatory
Bowel Disease at the MGH and collaborates with the
other members of the Center. In collaboration with
Dr. Cox Terhorst’s laboratory we have studied
the pathogenesis of Th-1 mediated models of colitis
in CD45RBhigh transfer model and bone marrow transplanted
CD3 tg mice. In the first model, colitis can be induced
by reconstitution of scid or Rag-2 KO mice with CD45RBhigh
CD4+ T cells from wild type mice. In the second model,
colitis develops after normal bone marrow cell reconstitution
of T cell deficient CD3 tg mice. In both models, colitis
develops due to lack of normal T cell regulation.
|